Current market catalysts

Redbook Retail Sales Index For September 2026 Vs September 2025: 8.3% YoY

Keybanc Maintains Overweight on InnovAge Holding, Raises Price Target to $14

Keybanc analyst Matthew Gillmor maintains InnovAge Holding (NASDAQ:INNV) with a Overweight and raises the price target from $13 to $14.

8-K filing — GENUINE PARTS CO (GPC)

Filed: 2026-09-09 AccNo: 0001193125-26-385959 Size: 224 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

BMO Capital Initiates Coverage On Gap with Market Perform Rating, Announces Price Target of $23

BMO Capital analyst Kelly Crago initiates coverage on Gap (NYSE:GAP) with a Market Perform rating and announces Price Target of $23.

8-K filing — CENTRUS ENERGY CORP (LEU)

Filed: 2026-09-09 AccNo: 0001628280-26-061036 Size: 911 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Baker Hughes Sees Chart Deal Unlocking $57 Billion Market

Baker Hughes (BKR) stock rose in premarket trading after raising its FY26 revenue guidance to $28.5B–$30.3B following the Chart acquisition.

GeneDx Partners With Beren Therapeutics To Launch The NPC GenomeComplete Sponsored Testing Program For Niemann-Pick Disease Type C

The program provides no-cost comprehensive genome sequencing for eligible pediatric patients with clinical findings, family history, or biomarker evidence suggestive of Niemann-Pick Disease Type C (NPC), helping address

Keybanc Maintains Overweight on Chime Financial, Raises Price Target to $40

Keybanc analyst Alex Markgraff maintains Chime Financial (NASDAQ:CHYM) with a Overweight and raises the price target from $33 to $40.

Medicare’s $2,000 Drug Cap Is Getting Expensive — More Than 1 in 5 Seniors Hit It as Drug Spending Heads Toward $346 Billion

Medicare drug spending faces fresh pressure as more seniors hit the $2,000 cap, raising concerns over costs.

SpaceX’s Starlink in Focus as FCC Moves to Expand Satellite Broadband Spectrum; To Vote on Sept. 30

FCC will vote on unlocking 1,000+ MHz of spectrum, potentially boosting Starlink capacity and satellite broadband competition.

Cheniere Energy, Freeport-McMoRan And A Financial Stock On CNBC’s ‘Final Trades’

CNBC's final trades spotlighted Pinnacle Financial, Cheniere Energy and Freeport-McMoRan, with analysts citing bullish outlooks and strong results.

Citizens Reiterates Market Outperform on Braze, Maintains $35 Price Target

Citizens analyst Patrick Walravens reiterates Braze (NASDAQ:BRZE) with a Market Outperform and maintains $35 price target.

Birchtech Announces It Will Begin Purchases Under Previously Authorized $5M Buyback Program On Or After September 14

E-Power Says Azusa, California City Council Authorized Staff To Pursue Exclusive Negotiating Agreement For Proposed Heavy-Duty Charging Station With Up To $26M Potential Investment; Says No Binding Commitment Exists

Trinity Biotech's Liquid Cooling Unit Trinovium Enters Contract With Red Team Investments, Owner Of Modular Data Center Technology X-MDC

The contract establishes a framework for Trinovium and RTI to develop and deploy direct-to-chip liquid cooling solutions for artificial intelligence ("AI"), high-performance computing ("HPC") and modular

Xeris Biopharma To Host XP‑8121 Program Overview Detailing Phase 3 Study And Commercial Opportunity; Topline Results Expected In Late 2028; FDA Approval And Launch Anticipated In 2030

Initiation of Phase 3 registrational study on track by year-end; topline results expected in late 2028; U.S. FDA approval and launch anticipated in 2030The Company expects XP-8121 peak net revenue potential of $1 to $3

Tenon Medical Repays Its Outstanding ~$5.16M Original Discount Senior Convertible Promissory Notes

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced that it has repaid

Propanc Biopharma Announces Plans To Start Phase 1b First-In-Human Study Of PRP In February 2027, Enrolling Up To 50 Patients With Advanced Solid Tumors In Australia; Says Ethics Submission Planned For November 2026

8-K filing — CENTERSPACE (CSR)

Filed: 2026-09-09 AccNo: 0001140361-26-035986 Size: 5 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — Xeris Biopharma Holdings, Inc. (XERS)

Filed: 2026-09-09 AccNo: 0001867096-26-000077 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

PRF Technologies Intends To Establish GridFeed Subsidiary

PRF Technologies Ltd. (Nasdaq: PRFX) ("PRF" or the "Company") today announced its plan to establish GridFeed™, together with its DeepSolar operations, as a standalone, wholly owned subsidiary, creating a

GlobalFoundries And Monolithic Power Systems Announce Long-Term Manufacturing Agreement To Deploy MPS Process Technology At GF's 300mm Singapore Facility, With Expanded Power Management Capacity In Early 2027

ENvue Medical Restarts Commercial Shipment Of PainShield Produced In U.S.

ENvue Medical , Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement and therapeutic technologies, today

Stephens & Co. Reiterates Overweight on Casey's General Stores, Maintains $975 Price Target

Stephens & Co. analyst Pooran Sharma reiterates Casey's General Stores (NASDAQ:CASY) with a Overweight and maintains $975 price target.

Nuwellis Says Financial Efficiency Strategy Drove Q2 2026 Gross Margin To 76% From 56%; Says It Had About $8.8M In Cash As Of August 31, With Runway Into Q3 2027

Aspire-Lakewood Holdings Announces $10M Stock Repurchase Program

This expanded share repurchase program is effective September 9, 2026. The expanded authorization reflects the Company's continued confidence in its long-term strategy as a holding company and strong free cash flow

IMUNON To Discuss OVATION 1 Clinical Study At Its Sept. 23 R&D Day

IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage biotechnology company developing DNA-mediated immunotherapies, today announced the agenda and speaker lineup for its upcoming R&D Day highlighting IMNN-001, the

Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market

Intelligent Bio Solutions submitted a 510(k) notification to the FDA for its fingerprint drug screening system to enter the US market.

8-K filing — bioAffinity Technologies, Inc. (BIAFW)

Filed: 2026-09-09 AccNo: 0001493152-26-041894 Size: 308 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — electroCore, Inc. (ECOR)

Filed: 2026-09-09 AccNo: 0001493152-26-041893 Size: 764 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits